Journal of Pharmaceutical Sciences 2014-10-01

Solubility and some crystallization properties of conglomerate forming chiral drug guaifenesin in water.

Robert R Fayzullin, Heike Lorenz, Zemfira A Bredikhina, Alexander A Bredikhin, Andreas Seidel-Morgenstern

Index: J. Pharm. Sci. 103(10) , 3176-82, (2014)

Full Text: HTML

Abstract

The solubility of 3-(2-methoxyphenoxy)-propane-1,2-diol, the well-known chiral drug guaifenesin 1, in water has been investigated by means of polythermal and isothermal approaches. It was found that the solubilities of racemic and enantiomeric diols rac- and (R)-1 depend strongly on temperature. The ternary phase diagram of the guaifenesin enantiomers in water in the temperature range between 10°C and 40°C was constructed. Clear evidence was obtained that rac-1 crystallizes as a stable conglomerate. The Meyerhoffer coefficient for the guaifenesin-water system is more than two and strongly depends on temperature. Neither crystalline hydrates nor polymorphs were detected within the range of conditions covered. Metastable zone width data with regard to primary nucleation were also collected for rac-1 and (R)-1. On the basis of the knowledge acquired, the resolution of racemic guaifenesin by preferential crystallization from solution could be realized successfully.© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.


Related Compounds

  • Guaifenesin

Related Articles:

Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices.

2014-07-01

[Vet. Ophthalmol. 17 Suppl 1 , 23-30, (2014)]

Experiment and modeling for the separation of guaifenesin enantiomers using simulated moving bed and Varicol units.

2014-10-10

[J. Chromatogr. A. 1363 , 242-9, (2014)]

Question: does guaifenesin improve outcomes in patients with cough associated with upper respiratory infection compared with no intervention?

2012-10-01

[J. Okla. State Med. Assoc. 105(10) , 397-8, (2012)]

Case report: anaphylactic reaction to guaifenesin.

2009-12-01

[Hosp. Pract. (Minneap) 37(1) , 60-3, (2009)]

Ephedrine- and guaifenesin-induced nephrolithiasis.

2004-12-01

[J. Altern. Complement. Med. 10(6) , 967-9, (2004)]

More Articles...